Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2014
12/17/2014CN102432616B 一种制备l-脯氨酰胺及其中间体的方法 An l- prolinamide and intermediates prepared
12/16/2014US8912343 Solid forms of (1r,4r)-6′-fluoro-(N, N-dimethyl)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and sulfuric acid
12/16/2014US8912341 Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones
12/16/2014US8912220 Compounds and methods of use thereof
12/16/2014US8912206 Pyrimidine ether derivatives and methods of use thereof
12/16/2014US8912187 Phthalazinone derivatives
12/16/2014US8912173 Substituted quinolines and their use as medicaments
12/11/2014US20140364455 Processes of making and crystalline forms of a mdm2 inhibitor
12/11/2014US20140364449 Method and system for identifying compounds that bind and/or activate a target opioid receptor in a ph-dependent manner
12/11/2014US20140364435 Amino-substituted imidazopyridazines
12/11/2014US20140364429 Antiviral compounds highly effective as hcv-ns5a inhibitor
12/11/2014US20140364419 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
12/11/2014US20140364395 Pyranyl Aryl Methyl Benzoquinolinone M1 Receptor Positive Allosteric Modulators
12/10/2014CN104203954A 三环磺酰胺化合物及其制备和使用方法 Tricyclic sulfonamide compounds and their preparation and use
12/10/2014CN104203940A 作为hcv抑制剂的杂双环衍生物 Heterobicyclic derivatives as inhibitors hcv
12/10/2014CN104193756A 一种从一叶荻中提取一叶荻碱的方法 A method to extract from the leaf Di Di leaf bases
12/10/2014CN104193755A 一种从三尖杉中提取三尖杉碱的方法 An extract from Cephalotaxaceae in Cephalotaxine methods
12/10/2014CN104193754A 一种从粉防己中提取粉防己碱的新方法 A new method of extracting Tetrandrine from tetrandra in
12/10/2014CN104193750A 通过抑制极光激酶抑制有丝分裂的化合物和方法 The compounds and methods of Aurora kinase inhibition by inhibiting mitosis
12/10/2014CN104193679A 从准噶尔乌头中提取分离生物碱的方法 Extracted from the Junggar Aconitum alkaloids isolated
12/10/2014CN104188973A 一种生物碱在制备预防或治疗肺纤维化药物组合物中的应用 An alkaloid in the preparation for preventing or treating pulmonary fibrosis in a pharmaceutical composition
12/10/2014CN103333676B 一种硒离子荧光探针及其制备方法和用途 One kind of selenium ions fluorescent probe and its preparation method and use
12/10/2014CN103113381B 系列水溶性羟基喜树碱环烷胺醇衍生物及其制法与用途 Series of water-soluble amine HCPT naphthenic their preparation and use of alcohol derivatives
12/10/2014CN103012418B 一种含1,3,4-噁二唑结构单元的罗丹明B类pH荧光探针及应用 Rhodamine B pH fluorescent probes and application of a 1,3,4-oxadiazole-containing structural units
12/10/2014CN102812005B β-分泌酶抑制剂 β- secretase inhibitors
12/10/2014CN102675327B 三尖杉酯碱类似物及制备方法和应用 Three harringtonine analogues and preparation method and application
12/10/2014CN102516152B 一种α-二氟羰基取代的手性叔醇类化合物及其合成方法和应用 One kind of α- difluoro-carbonyl-substituted chiral tertiary alcohol compound and its synthesis method and application
12/10/2014CN102470357B 催化剂前体、其制造方法、其使用方法以及使用其的反应器 Catalyst precursor, its manufacturing method, its use, and using the same reactor
12/09/2014US8907095 Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/09/2014US8906929 Inhibitors of human immunodeficiency virus replication
12/09/2014US8906922 Substituted triazoles useful as AXl inhibitors
12/09/2014US8906913 Azabicyclohexanes
12/04/2014US20140357868 Methods for stereoselective reduction
12/04/2014US20140357655 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists
12/04/2014US20140357647 7-substituted hanfangichin b derivative, and preparation method and use thereof
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140356873 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
12/02/2014US8901345 Process for preparation of optically active diamine derivative salt
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901175 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
12/02/2014US8901169 Neprilysin inhibitors
12/02/2014US8901149 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
12/02/2014US8901139 Tricyclic indole derivatives and methods of use thereof
12/02/2014US8901117 Small molecule inhibitors of MDM2 and the uses thereof
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
11/2014
11/27/2014US20140350244 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
11/27/2014US20140350020 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
11/27/2014US20140350011 Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
11/27/2014US20140349995 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
11/27/2014US20140349993 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/25/2014US8895733 Triazine-oxadiazoles
11/25/2014US8895729 Process for making thienopyrimidine compounds
11/25/2014US8895604 Solid forms of (1r,4r)-6′-fluoro-N,N-dimethy1-4-phenyl-4′,9′-dihydro-3′ H-spiro-[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine hydrochloride
11/25/2014US8895577 Compounds and compositions as TLR activity modulators
11/25/2014US8895576 Methods of use of cyclopamine analogs
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8894989 PARP inhibitor compounds, compositions and methods of use
11/20/2014US20140343294 Pharmaceutical compounds
11/20/2014US20140343283 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof
11/20/2014US20140343278 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343092 Pyrrolopyridinone Compounds And Methods For Treating HIV
11/20/2014US20140343089 Norepinephrine and selective serotonin receptor blocker and use thereof
11/20/2014US20140343088 Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof
11/20/2014US20140343082 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof
11/20/2014US20140343047 Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof
11/20/2014US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
11/20/2014US20140343039 Process for preparing cephalotaxine esters
11/20/2014US20140343033 Azaindole derivatives
11/20/2014US20140343032 Novel 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
11/20/2014US20140343029 Novel Imidazole Amines as Modulators of Kinase Activity
11/20/2014US20140343015 Morphinan derivative
11/20/2014US20140341851 Novel benzimidazole derivatives
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889862 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/18/2014US8889855 Preparation of maytansinoid esters
11/18/2014US8889854 C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
11/18/2014US8889718 Thiazole derivatives
11/18/2014US8889711 Pyrazolopyridine derivatives as anticancer agent
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889705 Noscapine analogs and their use in treating cancers
11/18/2014US8889704 Triazolopyridine compounds as PIM kinase inhibitors
11/13/2014US20140336391 Process for the preparation of asenapine intermediate
11/13/2014US20140336390 Synthetic methods for spiro-oxindole compounds
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336182 Aurora Kinase Modulators and Method of Use
11/13/2014US20140336170 Indazole compounds useful as ketohexokinase inhibitors
11/13/2014US20140336169 Imidazopyrazine syk inhibitors
11/13/2014US20140336166 Novel purine derivatives and their use in the treatment of disease
11/13/2014US20140336165 Dihydroxy aromatic heterocyclic compound
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8883889 Pigment compositions comprising pyrrolo[3,4-c]pyrroles
11/11/2014US8883840 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883819 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
11/11/2014US8883807 Piperidinone carboxamide indane CGRP receptor antagonists
11/11/2014US8883799 Tricyclic PI3K inhibitor compounds and methods of use
11/11/2014US8883790 Pharmaceutical combinations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 298